Consensus recommendations for the use of automated insulin delivery technologies in clinical practice

M Phillip, R Nimri, RM Bergenstal… - Endocrine …, 2023 - academic.oup.com
The significant and growing global prevalence of diabetes continues to challenge people
with diabetes (PwD), healthcare providers, and payers. While maintaining near-normal …

[HTML][HTML] Current advances of artificial pancreas systems: a comprehensive review of the clinical evidence

SJ Moon, I Jung, CY Park - Diabetes & Metabolism Journal, 2021 - synapse.koreamed.org
Abstract Since Banting and Best isolated insulin in the 1920s, dramatic progress has been
made in the treatment of type 1 diabetes mellitus (T1DM). However, dose titration and timely …

Human hypoimmune primary pancreatic islets avoid rejection and autoimmunity and alleviate diabetes in allogeneic humanized mice

X Hu, C Gattis, AG Olroyd, AM Friera, K White… - Science translational …, 2023 - science.org
Transplantation of allogeneic pancreatic donor islets has successfully been performed in
selected patients with difficult-to-control insulin-dependent diabetes and impaired …

A fully artificial pancreas versus a hybrid artificial pancreas for type 1 diabetes: a single-centre, open-label, randomised controlled, crossover, non-inferiority trial

MA Tsoukas, D Majdpour, JF Yale, A El Fathi… - The Lancet Digital …, 2021 - thelancet.com
Background For people with type 1 diabetes, there is currently no automated insulin delivery
system that does not require meal input. We aimed to assess the efficacy of a novel faster …

A systematic review of commercial hybrid closed-loop automated insulin delivery systems

S Peacock, I Frizelle, S Hussain - Diabetes Therapy, 2023 - Springer
Introduction Several different forms of automated insulin delivery systems (AID systems)
have recently been developed and are now licensed for type 1 diabetes (T1D). We …

Management of type 1 diabetes in pregnancy: update on lifestyle, pharmacological treatment, and novel technologies for achieving glycaemic targets

K Benhalima, K Beunen, SE Siegelaar… - The Lancet Diabetes & …, 2023 - thelancet.com
Glucose concentrations within target, appropriate gestational weight gain, adequate lifestyle,
and, if necessary, antihypertensive treatment and low-dose aspirin reduces the risk of pre …

Fully closed-loop glucose control compared with insulin pump therapy with continuous glucose monitoring in adults with type 1 diabetes and suboptimal glycemic …

CK Boughton, S Hartnell, R Lakshman… - Diabetes …, 2023 - Am Diabetes Assoc
OBJECTIVE We evaluated the safety and efficacy of fully closed-loop with ultrarapid insulin
lispro in adults with type 1 diabetes and suboptimal glycemic control compared with insulin …

A multicenter randomized trial evaluating fast-acting insulin aspart in the bionic pancreas in adults with type 1 diabetes

Bionic Pancreas Research Group, RW Beck… - Diabetes Technology …, 2022 - liebertpub.com
Objective: To evaluate the insulin-only configuration of the iLet® bionic pancreas (BP) using
fast-acting insulin aspart (Fiasp®) in adults with type 1 diabetes (T1D). Research Design …

Automated insulin delivery systems: from early research to routine care of type 1 diabetes

E Renard - Acta Diabetologica, 2023 - Springer
Automated insulin delivery (AID) systems, so-called closed-loop systems or artificial
pancreas, are based upon the concept of insulin supply driven by blood glucose levels and …

Real-world evidence analysis of a hybrid closed-loop system

H Alwan, ME Wilinska, Y Ruan… - Journal of diabetes …, 2023 - journals.sagepub.com
Background: We analyzed real-world evidence to assess the performance of the mylife
CamAPS FX hybrid closed-loop system. Methods: Users from 15 countries across different …